Health & Fitness
5 min read
Wolverhampton Urges Cervical Cancer Screening & Vaccination
Yahoo News New Zealand
January 20, 2026•2 days ago
AI-Generated SummaryAuto-generated
Cervical Cancer Prevention Week is underway, with calls for Wolverhampton residents to prioritize screening and HPV vaccination. The campaign aims to eliminate cervical cancer by detecting high-risk HPV, a primary cause. Councillor Obaida Ahmed emphasized the preventable nature of the disease, noting that two women die daily from it in England. The HPV vaccine is offered to young people and eligible adults to prevent infection.
People in Wolverhampton are being urged to get screened and vaccinated in a bid to eliminate cervical cancer as part of an awareness event.
Cervical Cancer Prevention Week started on Monday and the city council said it wanted to make sure women prioritised getting screened.
The appointments check for the high-risk Human Papillomavirus (HPV), the main cause of the cancer.
"Two women die every day from cervical cancer in England, yet it is one of the most preventable cancers – and getting vaccinated and screened can help stop it before it starts," councillor Obaida Ahmed said.
"You will be supported by well qualified staff during your screening appointment and if you do feel nervous about having the test, they can help to reassure you."
The HPV vaccine is offered each year to boys and girls aged 12 to 13 to help protect them against catching the infection.
It can also be given to those up to age 45 with immune-compromised conditions and to men who have sex with other men.
Ahmed said the authority wanted parents of those youngsters eligible for the vaccine to give their consent as "it is crucial in our drive to eliminate the disease".
Follow BBC Wolverhampton & Black Country on BBC Sounds, Facebook, X and Instagram.
More on this story
Young people urged to get HPV vaccine
Smear test 'saved my life' after detecting cancer
What is the HPV vaccine and who can get it?
Related internet links
Rate this article
Login to rate this article
Comments
Please login to comment
No comments yet. Be the first to comment!
